why choose us

🌐 Go to WebHealthNetwork.com
Go to Consumers Chat
First received: July 22, 2025

Clinical Trial: A Study in Healthy Men to Test How Bosentan Influences the Amount of Nerandomilast in the Blood

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Healthy

Study Type: INTERVENTIONAL


Official Title: The Effect of Multiple Oral Doses of Bosentan on the Single Oral Dose Pharmacokinetics of Nerandomilast in Healthy Male Subjects (an Open-label, Two-treatment, Two-period Fixed Sequence Trial)

Brief Summary: The main objective of this trial is to investigate the effect of bosentan, a moderate Cytochrome P450 (CYP) 3A inducer on the single dose pharmacokinetics of nerandomilast.

Read more